(Q27824867)
Statements
2 references
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer (English)
Astrid Lièvre
Delphine Le Corre
Bruno Landi
Jean-François Emile
Jean-François Côté
Gorana Tomasic
Christophe Penna
Michel Ducreux
Philippe Rougier
Frédérique Penault-Llorca
Identifiers
2 references
2 references